Concepedia

Naveena B. Janakiram

NB

22

Publications

874

Citations

17

H-Index

2008

Active since

Affiliations

University of Oklahoma Health Sciences Center(Current)

National Cancer Institute

Prevention Group

Oklahoma City VA Medical Center

Walter Reed National Military Medical Center

Naveena B. Janakiram is an author at University of Oklahoma Health Sciences Center specializing in medicine, tumor biology, and pharmacology.

Top concepts

Publications per year

2008–2023

22

Publications

22

Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling

Altaf Mohammed, Naveena B. Janakiram, Misty Brewer et al. · Translational Oncology · 2013 · 140 citations · Full text

Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48<sup>Cre/+</sup> LSL‐Kras<sup>G12D/+</sup> mice

Altaf Mohammed, Qian Li, Naveena B. Janakiram et al. · International Journal of Cancer · 2012 · 75 citations · Full text

, , +20

Loss of natural killer T cells promotes pancreatic cancer in <scp>LSL</scp>‐Kras<sup>G12D/+</sup> mice

Naveena B. Janakiram, Altaf Mohammed, Taylor Bryant et al. · Immunology · 2017 · 64 citations · Full text

Molecular Pathways: Mucins and Drug Delivery in Cancer

Chinthalapally V. Rao, Naveena B. Janakiram, Altaf Mohammed · Clinical Cancer Research · 2016 · 61 citations · Full text

Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling

Altaf Mohammed, Naveena B. Janakiram, Venkateshwar Madka et al. · Cancer Prevention Research · 2014 · 58 citations · Full text

, , +16

Rows per page

1–5 of 22